C2 Therapeutics, Inc.

C2 Therapeutics, Inc.

C2 Therapeutics, Inc.

Date Founded



303 Convention Way,Suite 1,Redwood City, CA 94063

Type of Company



Medical Products & Equipment
Hospitals & Patient Services

Company Description

C2 Therapeutics, Inc. develops treatment for esophageal cancer. Its Coldplay CryoBalloon Focal Ablation System sets a new standard for simplicity in ablation of Barrett’s Esophagus. The company was founded by Peter Garcia-Meza in 2007 and is headquartered in Redwood City, CA.

Executives & Employees

President & Chief Executive Officer

Chief Operating Officer

Director of Clinical Research

Director-Research & Development

Vice President-Europe

Vice President, Sales

Vice President, Finance

Vice President of Regulatory & Quality

Board of Directors

Former Consultant at McKinsey & Co., Inc.

Director at Rodo Medical, Inc.

Founder at Alembic LLC

Treasurer/Vice President, Finance at Saint Vincent College

Co-Founder at C2 Therapeutics, Inc.

Paths to C2 Therapeutics, Inc.
Potential Connections via
Relationship Science
C2 Therapeutics, Inc.
Recent Transactions
Details Hidden

Pentax Medical Co., Hoya Corp. purchase C2 Therapeutics, Inc. from Main Line Equity Partners LLC, Synergy Ventures, De Novo Ventures

Details Hidden

C2 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

C2 Therapeutics, Inc. raised money in a private placement transaction

Advisors & Consultants
Legal Advisor

Partner at King & Spalding LLP

Details Hidden

Chief Operating Officer at C2 Therapeutics, Inc.

Details Hidden

Main Line Equity Partners is focused on investing in profitable, next stage growth companies, with under $10 million in revenue, looking to engage strategic break-through capital and operational support to increase market share and accelerate earnings growth. We invest at this end of the lower middle market as our collective experience has taught us that this is where the greatest opportunities for outsized returns exist. Our philosophy is built on the belief that the highest returns are achieved through a financial and operational partnership. Main Line Equity Partners provides a stable platform to manage growth alongside strong, forward-thinking management teams. We are committed to adding value to our portfolio companies by delivering the resources to unlock value and developing sensible, realistic deal structures that mitigate risk.

Details Hidden

President & Chief Executive Officer at C2 Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by C2 Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of C2 Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and C2 Therapeutics, Inc..